Early systemic device embolization after transcatheter patent foramen ovale closure

Journal of Invasive Cardiology

Volumn 18, Issue 3, 2006, Pages

  Aubry, Pierre C ^a   Juliard, Jean Michel ^a   Brochet, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN INFARCTION; CASE REPORT; CORONARY ARTERY DISEASE; DESCENDING AORTA; DEVICE; DEVICE REMOVAL; DOPPLER FLOWMETRY; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMPLANTATION; LUNG EMBOLISM; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED, 80 AND OVER; AORTA, THORACIC; AORTIC DISEASES; AORTOGRAPHY; CATHETER ABLATION; DEVICE REMOVAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; FOREIGN-BODY MIGRATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE;

EID: 33645850407     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Khairy P, O'Donnell CP, Landzberg MJ, et al. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboembolic. A systematic review. Ann Intern Med 2003;139:753-760.
2. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44;750-758.
3. Marshall AC, Lock JE. Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am Heart J 2000;140:303-307.
4. Amarenco P. Patent foramen and the risk of stroke. Smoking gun or guilty by association? Heart 2005;91:441-443.
5. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
6. Martin F, Sanchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
7. Sievert H, Horvath K, Zadan E, et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Intervent Cardiol 2001;14:261-266.
8. Beitzke A, Schuchlenz H, Gamillscheg A, et al. Catheter closure of the persistent foramen ovale: Mid-results in 162 patients. J Intervent Cardiol 2001;14:223-230.
9. Alameddine F, Block PC. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: acute results from the FORECAST registry. Catheter Cardiovasc Interv 2004;62:512-516.
10. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25:424-430.
11. Schwerzmann M, Windecker S, Wahl A, et al. Percutaneous closure of patent foramen ovale: Impact of device design on safety and efficacy. Heart 2004;90:186-190.
12. Berdat PA, Chaterjee T, Pfammatter J-P, et al. Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg 2000;120:1034-1039.